(Q42990603)

12 November 2017

title

Molecular epidemiology of hepatitis C in Australia (English)

1 reference

12 November 2017

0 references

1 reference

Kaba S

1

1 reference

12 November 2017

Dutta U

2

1 reference

12 November 2017

Byth K

3

1 reference

12 November 2017

Crewe EB

4

1 reference

12 November 2017

Khan MH

5

1 reference

12 November 2017

Coverdale SA

6

1 reference

12 November 2017

Lin R

7

1 reference

12 November 2017

Liddle C

8

1 reference

12 November 2017

Farrell GC

9

1 reference

12 November 2017

publication date

1 September 1998

1 reference

Journal of Gastroenterology and Hepatology

12 November 2017

published in

1 reference

12 November 2017

volume

13

1 reference

12 November 2017

issue

9

1 reference

12 November 2017

page(s)

914-920

1 reference

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00761.X

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00761.X

Genetic organization and diversity of the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00761.X

Hepatitis C virus: molecular biology and genetic variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00761.X

Variability of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00761.X

The molecular virology of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00761.X

Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00761.X

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00761.X

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00761.X

Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00761.X

Hepatitis C genotypes: the key to pathogenicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00761.X

Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00761.X

Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00761.X

Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00761.X

Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00761.X

Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00761.X

Hepatitis C virus genotypes in France: comparison of clinical features of patients infected with HCV type I and type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00761.X

Hepatitis C virus (HCV) genotype distribution in German isolates: studies on the sequence variability in the E2 and NS5 region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00761.X

Efficacy and tolerance of a 6-month treatment course of daily interferon-alpha 2a for chronic hepatitis C with cirrhosis. The Australian Hepatitis C Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00761.X

Prevalence of hepatitis C virus and genotype distribution in an Australian volunteer blood donor population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00761.X

Distribution of hepatitis C virus genotypes in German patients with chronic hepatitis C: correlation with clinical and virological parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1998.TB00761.X

10.1111/J.1440-1746.1998.TB00761.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference